Skip to main content
SpringerLink
Log in

Methotrexate sensitivity in Down's syndrome: a hypothesis

  • Letter to the Editors
  • Methotrexate, Down's Syndrome
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Allegra CJ, Fine RL, Drake JC, Chabner BA (1986) The effect of methotrexate on intracellular folate pools in human MCF-7 breast cancer cells. Evidence for direct inhibition of purine synthesis. J Biol Chem 261: 6478–6485

    Google Scholar 

  2. Barak AJ, Tuma DI, Beckenhauer HC (1984) Methotrexate hepatotoxicity. J Am Coll Nutr 3: 93–96

    Google Scholar 

  3. Baram J, Allegra CJ, Fine RL, Chabner BA (1987) Effect of methotrexate on intracellular folate pools in purified myeloid precursor cells from normal human bone marrow. J Clin Invest 79: 692–697

    Google Scholar 

  4. Bunni M, Doig MT, Donato H, Kesavan V, Priest DG (1988) Role of methylenetetrahydrofolate depletion in methotrexatemediated intracellular thymidylate synthesis inhibition in cultured L1210 cells. J Biol Chem 48: 3398–3404

    Google Scholar 

  5. Chadefaux B, Rethore MO, Raoul O, Ceballos I, Poissonnier M, Gilgenkrantz S, Allard D (1988) Cystathionine beta synthase: gene dosage effect of trisomy 21. Biochem Biophys Res Commun 128: 40–44

    Google Scholar 

  6. Chadefaux B, Ceballos I, Hamet M, Coude M, Poissonnier M, Kamoun P, Allard D (1988) Is absence of atheroma in Down's syndrome due to decreased homocysteine levels? Lancet II: 741

    Google Scholar 

  7. Chanarin I, Deacon R, Lumb M, Muir M, Perry J (1985) Cobalamin-folate interrelations: a critical review. Blood 66: 479–489

    Google Scholar 

  8. Cheng FW, Shane B, Stokstad ELRN (1975) The anti-folate effect of methionine on bone marrow of normal and vitamin B 12-deficient rats. Br J Haematol 31: 323–336

    Google Scholar 

  9. Cichowicz DJ, Shane B (1987) Mammalian folylpoly-γ-glutamate synthetase: 2. Substrate specificity and kinetic properties. Biochemistry 26: 513–521

    Google Scholar 

  10. Garre ML, Relling MV, Kalwinsky D, Dodge R, Crom WR, Abromowitch M, Pui CH, Evans WE (1987) Pharmacokinetics and toxicity of methotrexate in children with Down's syndrome and acute lymphocytic leukemia. J Pediatr 111: 606–612

    Google Scholar 

  11. Gericke GS, Hesseling PB, Brink S, Tiedt FC (1977) Leucocyte ultrastructure and folate metabolism in Down's syndrome. S Afr Med J 51: 369–373

    Google Scholar 

  12. Hards RG, Benkovic SJ, Van Keuren ML, Graw SL, Drabkin HA, Patterson D (1986) Assignment of a third purine biosynthetic gene (glycinamide ribonucleotide transformylase) to human chromosome 21. Am J Hum Genet 39: 179–185

    Google Scholar 

  13. Kroes ACM, Lindemans J, Schoester M, Abels J (1986) Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide. Cancer Chemother Pharmacol 17: 114–120

    Google Scholar 

  14. Matherly LH, Seither RL, Goldman ID (1987) Metabolism of diaminoantifolates: biosynthesis and pharmacology of the 7-hydroxyl and polyglutamyl metabolites of methotrexate and related antifolates. Pharmacol Ther 35: 27–56

    Google Scholar 

  15. Miller RW (1970) Neoplasia and Down's syndrome. Ann NY Acad Sci 171: 637–644

    Google Scholar 

  16. Mudd SH, Levy HL (1983) Disorders of transsulfuration. In: Standbury JB (ed) Metabolic basis of inherited diseases. McGraw-Hill, New York, pp 522–559

    Google Scholar 

  17. Patterson D, Graw S, Jones C (1981) Demonstration by somatic cell genetics of coordinate regulation of genes for two enzymes of purine synthesis assigned to human chromosome 21. Proc Natl Acad Sci USA 78: 405–409

    Google Scholar 

  18. Peeters M, Poon A (1987) Down's syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity. Eur J Pediatr 146: 416–422

    Google Scholar 

  19. Refsum H, Ueland PM, Kvinnsland S (1986) Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res 46: 5385–5391

    Google Scholar 

  20. Refsum H, Helland S, Ueland PM (1989) Fasting plasma homocysteine as a sensitive parameter of antifolate effect. A study on psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther (in press)

  21. Rhee MS, Johnson TB, Priest DG, Galivan J (1989) The effect of methionine on methotrexate metabolism in rat hepatocytes in monolayer culture. Biochim Biophys Acta 1011: 122–128

    Google Scholar 

  22. Shane B (1986) Folylpoly-γ-glutamate synthetase. In: Cooper BA, Whitehead VM (eds) Chemistry and biology of Pteridines 1986, Walter de Gruyter, Berlin New York, pp 719–728

    Google Scholar 

  23. Steinberg SE (1984) Mechanism of folate homeostasis. Am J Physiol 246: G319-G324

    Google Scholar 

  24. Ueland PM, Refsum H, Male R, Lillehaug J (1986) Disposition of endogenous homocysteine by mouse fibroblast C3H/10T1/2 CI 8 and the chemically transformed C3H/10T1/2MCA CI 16 cells following methotrexate exposure. J Natl Cancer Inst 77: 283–289

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Clinical Pharmacology Unit, Department of Pharmacology and Toxicology, University of Bergen, N-5021, Bergen, Norway

    P. M. Ueland, H. Refsum & B. Christensen

Authors
  1. P. M. Ueland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Refsum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Christensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueland, P.M., Refsum, H. & Christensen, B. Methotrexate sensitivity in Down's syndrome: a hypothesis. Cancer Chemother. Pharmacol. 25, 384–386 (1990). https://doi.org/10.1007/BF00686245

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686245

Keywords

Search

Navigation